Pavese, F.; Capoluongo, E.D.; Muratore, M.; Minucci, A.; Santonocito, C.; Fuso, P.; Concolino, P.; Di Stasio, E.; Carbognin, L.; Tiberi, G.;
et al. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 2022, 14, 4571.
https://doi.org/10.3390/cancers14194571
AMA Style
Pavese F, Capoluongo ED, Muratore M, Minucci A, Santonocito C, Fuso P, Concolino P, Di Stasio E, Carbognin L, Tiberi G,
et al. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers. 2022; 14(19):4571.
https://doi.org/10.3390/cancers14194571
Chicago/Turabian Style
Pavese, Francesco, Ettore Domenico Capoluongo, Margherita Muratore, Angelo Minucci, Concetta Santonocito, Paola Fuso, Paola Concolino, Enrico Di Stasio, Luisa Carbognin, Giordana Tiberi,
and et al. 2022. "BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making" Cancers 14, no. 19: 4571.
https://doi.org/10.3390/cancers14194571
APA Style
Pavese, F., Capoluongo, E. D., Muratore, M., Minucci, A., Santonocito, C., Fuso, P., Concolino, P., Di Stasio, E., Carbognin, L., Tiberi, G., Garganese, G., Corrado, G., Di Leone, A., Generali, D., Fragomeni, S. M., D’Angelo, T., Franceschini, G., Masetti, R., Fabi, A.,
... Paris, I.
(2022). BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers, 14(19), 4571.
https://doi.org/10.3390/cancers14194571
